Efficacy of CS-834 against experimental pneumonia caused by penicillin- susceptible and -resistant Streptococcus pneumoniae in mice

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 1, 1998, Pages 23-27

  Fukuoka, Takashi ^a   Kawada, Harumi ^a   Kitayama, Akiko ^a   Koga, Tetsufumi ^a   Kubota, Mikie ^a   Harasaki, Tamako ^a   Kamai, Yasuki ^a   Ohya, Satoshi ^a   Yasuda, Hiroshi ^a   Iwata, Masayuki ^a   Kuwahara, Shogo ^b  

^a DAIICHI SANKYO CO   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID PIVALOYLOXYMETHYL ESTER; CARBAPENEM; CEFDINIR; CEFDITOREN PIVOXIL; CEFPODOXIME PROXETIL; CEFTERAM PIVOXIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; CELL VIABILITY; DRUG EFFICACY; DRUG POTENCY; IMMUNE DEFICIENCY; INCIDENCE; INOCULATION; MORBIDITY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0031982850     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.1.23     Document Type: Article

References (21)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumuniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Austrian, R. 1986. Pneumococcal pneumonia. Diagnosis, epidemiologic, therapeutic and prophylactic considerations. Chest 90:738-743.
3. Azoulay-Dupuis, E., E. Vallée, B. Veber, J. P. Bédos, J. Bauchet, and J. J. Pocidalo. 1992. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrob. Agents Chemother. 36:2698-2703.
4. Caputo, G. M., P. C. Appelbaum, and H. H. Liu. 1993. Infections due to penicillin-resistant pneumococci. Clinical, epidemiologic, and microbiologic features. Arch. Intern. Med. 153:1301-1310.
5. Committee for Revision of MIC Determination Method. 1981. Revision of minimal inhibitory concentration (MIC) determination method. Chemotherapy (Tokyo) 29:76-79.
6. Feldman, C., J. M. Kallenbach, S. D. Miller, J. R. Thorburn, and H. J. Koornhof. 1985. Community-acquired pneumonia due to penicillin-resistant pneumococci. N. Engl. J. Med. 313:615-617.
7. Hisaoka, M., M. Ichikawa, and T. Terao. 1991. Microbiological assay method for the determination of panipenem concentrations in body fluids. Chemotherapy (Tokyo). 39(Suppl. 3):190-196.
8. Konno, M., and Working Group for Penicillin-Resistant Streptococcus pneumoniae. 1994. An epidemiological study of penicillin-resistant Streptococcus pneumoniae in Japan. Jpn. J. Assoc. Infect. Dis. 68:1338-1351.
9. MacFarlane, J. T., R. G. Finch, M. J. Ward, and A. D. MacRae. 1982. Hospital study of adult community-acquired pneumonia. Lancet ii:255-258.
10. Moine, P., E. Vallée, E. Azoulay-Dupuis, P. Bourget, J. P. Bédos, J. Bauchet, and J. J. Pocidalo. 1994. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob. Agents Chemother. 38:1953-1958.
11. Neu, H. C. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
12. Neu, H. C., G. Saha, and N.-X. Chin. 1989. Comparative in vitro activity and β-lactamase stability of FK482. a new oral cephalosporin. Antimicrob. Agents Chemother. 33:1795-1800.
13. Ohya, S., T. Fukuoka, T. Koga, T. Takenouchi, H. Kawada, T. Harasaki, A. Hirasawa, C. Ishii, E. Sakagawa, M. Kubota, H. Yasuda, M. Iwata, and S. Kuwahara. 1996. CS-834, a new oral carbapenem. III. In vivo evaluation of CS-834, abstr. F107, p. 118. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
14. Okamoto, S., Y. Hamana, M. Inoue, and S. Mitsuhashi. 1987. In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral β-lactam antibiotics. Antimicrob. Agents Chemother. 31:1111-1116.
15. Pallarés, R., J. Liñares, M. Vadillo, C. Cabellos, F. Manresa, P. F. Viladrich, R. Martín, and F. Gudiol. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:474-480.
16. Smith, G. M., and K. H. Abbott. 1994. Development of experimental respiratory infections in neutropenic rats with either penicillin-resistant Streptococcus pneumoniae or β-lactamase-producing Haemophilus influenzae. Antimicrob. Agents Chemother. 38:608-610.
17. Spika, J. S., R. R. Facklam, B. D. Plikaytis, M. J. Oxtoby, and the Pneumococcal Surveillance Working Group. 1991. Antimicrobial resistance of Streptococcus pneumoniae in the United States. 1979-1987. J. Infect. Dis. 163: 1273-1278.
18. Tamura, A., R. Okamoto, T. Yoshida, H. Yamamoto, S. Kondo, M. Inoue, and S. Mitsuhashi. 1988. In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin. Antimicrob. Agents Chemother. 32: 1421-1426.
19. Tateda, K., K. Takashima, H. Miyazaki, T. Matsumnto, T. Hatori, and K. Yamaguchi. 1996. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model. Antimicrob. Agents Chemother. 40:1520-1525.
20. Utsui, Y., M. Inoue, and S. Mitsuhashi. 1987. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin. Antimicrob. Agents Chemother. 31:1085-1092.
21. Utsui, Y., T. Takenouchi, N. Masuda, H. Domon, M. Kakuta, C. Ishii, C. Ishii, E. Sakagawa, T. Abe, S. Ohya, H. Yasuda, M. Iwata, and S. Kuwahara. 1996. CS-834, a new oral carbapenem. II. In vitro evaluation of R-95867, the active metabolite of CS-834, abstr. F106. p. 118. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.